No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996–2013

References

• Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, etal. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014; 14: 742–50.
   PubMed Web of Science ®Google Scholar
• Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, etal. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015; 6: 22–9.
   Google Scholar
• Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17: 697–728.
   Google Scholar
• Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008; 8: 93.
   Google Scholar
• Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, etal. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004; 48: 4624–30.
   Google Scholar
• Zhou Z, Li X, Chen X, Luo F, Pan C, Zheng X, etal. Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. Antimicrob Agents Chemother. 2015; 59: 1048–51.
   Google Scholar
• Liu X, Jiang Y, Chen X, Li J, Shi D, Xin D. Drug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics. Biomed Res Int. 2014; 2014: 320801. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Xue G, Wang Q, Yan C, Jeoffreys N, Wang L, Li S, etal. Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China. J Clin Microbiol. 2014; 52: 1478–82.
   Google Scholar
• Rasmussen JN, Voldstedlund M, Andersen RL, Ellermann-Eriksen S, Jensen TG, Johansen HK, etal. Increased incidence of Mycoplasma pneumoniae infections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill. 2010; 15 pii=19708..
   Google Scholar
• Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bebear C. The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin Microbiol Infect. 2013; 19: E212–17.
   Google Scholar
• Dumke R, Luck C, Jacobs E. Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012. J Antimicrob Chemother. 2013; 57: 3460.
   Google Scholar
• Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011; 17: 1079–82.
   Google Scholar
• Zheng X, Lee S, Selvarangan R, Qin X, Tang YW, Stiles J, etal. Macrolide-resistant Mycoplasma pneumoniae, United States. Emerg Infect Dis. 2015; 21: 1470–2.
   Google Scholar
• Bebear C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011; 6: 423–31.
   Google Scholar
• Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, etal. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis. 2010; 67: 355–8.
   Google Scholar
• Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, etal. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009; 64: 52–8.
   Google Scholar
• Spuesens EB, Hoogenboezem T, Sluijter M, Hartwig NG, van Rossum AM, Vink C. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods. 2010; 82: 214–22.
   Google Scholar
• Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008; 52: 3542–9.
   Google Scholar
• Nilsson AC, Jensen JS, Bjorkman P, Persson K. Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides. Scand J Infect Dis. 2014; 46: 315–19.
   Google Scholar
• Gullsby K, Storm M, Bondeson K. Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR. J Clin Microbiol. 2008; 46: 727–31.
   Google Scholar
• Agresti A, Coull B. Approximate is better than ‘Exact’ for interval estimation of binomial proportions. Am Stat. 1998; 52: 119–29.
   Web of Science ®Google Scholar
• Dumke R, Stolz S, Jacobs E, Juretzek T. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia. Int J Infect Dis. 2014; 29: 197–9.
   Google Scholar
• Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, etal. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011; 66: 734–7.
   Google Scholar
• Läkemedelsverket. Farmakologisk behandling av nedre luftvägsinfektioner i öppen vård. 2008; Swedish: Läkemedelsverket. 3.
   Google Scholar
• Svenska Infektionsläkarföreningen. Vårdprogram för samhällsförvärvad pneumoni. 2011; Swedish: Svenska Infektionsläkarföreningen.
   Google Scholar
• Linde A, Ternhag A, Torner A, Claesson B. Antibiotic prescriptions and laboratory-confirmed cases of Mycoplasma pneumoniae during the epidemic in Sweden in 2011. Euro Surveill. 2012; 17 pii=20082..
   Google Scholar
• Anagrius C, Lore B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One. 2013; 8: e61481.
   Google Scholar
• Läkemedelsverket. Sexuellt överförbara bakteriella infektioner – behandlingsrekommendation: information från Läkemedelsverket. 2015; Läkemedelsverket: Swedish. 26.
   Google Scholar
• Swedres-Svarm. Public health agency of Sweden and National veterinary institute. Consumption of antibiotics and occurrence of antibiotic resistance in Sweden. 2014. Available from: https://www.folkhalsomyndigheten.se/pagefiles/20281/Swedres-Svarm-2014-14027.pdf [cited 19 April 2016]..
   Google Scholar
• European Centre for Disease prevention and Control. Antimicrobial consumption interactive database: ESAC-Net. Antimicrobial consumption rates by country. Available from: esac-net-database/Pages/Antimicrobial-consumption-rates-by-country.aspx [cited 19 April 2016]..
   Google Scholar
• Bergman M, Huikko S, Huovinen P, Paakkari P, Seppala H, Finnish Study Group for Antimicrobial R. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2006; 50: 3646–50.
   Google Scholar
• Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis. 2005; 11: 829–37.
   Google Scholar
• Cardinale F, Chironna M, Chinellato I, Principi N, Esposito S. Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol. 2013; 51: 723–4.
   Google Scholar
• Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2014; 58: 1034–8.
   Google Scholar